MFGE8 promotes gastric cancer progression by activating the IL-6/JAK/STAT3 signaling

IF 3.7 2区 生物学 Q2 CELL BIOLOGY Cellular signalling Pub Date : 2025-01-01 Epub Date: 2024-10-25 DOI:10.1016/j.cellsig.2024.111486
Long-long Ding , Meng Zhang , Tao Zhang , Hui Liu , Peng-fei Liu
{"title":"MFGE8 promotes gastric cancer progression by activating the IL-6/JAK/STAT3 signaling","authors":"Long-long Ding ,&nbsp;Meng Zhang ,&nbsp;Tao Zhang ,&nbsp;Hui Liu ,&nbsp;Peng-fei Liu","doi":"10.1016/j.cellsig.2024.111486","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Gastric cancer is malignant cancer with high morbidity and mortality worldwide. Milk fat globule EGF and factor V/VIII domain containing (MFGE8) was involved in many cancers. Nevertheless, the role of MFGE8 in gastric cancer remained indistinct. To probe the role of MFGE8 in gastric cancer and further explore the regulating mechanism.</div></div><div><h3>Methods</h3><div>GEPIA was employed for analysis of MFGE8 expression and survival of gastric cancer patients. MFGE8 expression in gastric cancer was determined by immunohistochemistry, PCR, and western blot. The effect of MFGE8 on gastric cancer cells were evaluated by a series of cell function experiments. The mechanism of MFGE8 on gastric cancer was analyzed by GSEA and verified by in vitro and in vivo experiments.</div></div><div><h3>Results</h3><div>MFGE8 was over-expressed in gastric cancer. Silence of MFGE8 suppressed cell viability, proliferated ability, migrated and invasive ability, and EMT, but accelerated cell apoptosis. The opposite results were obtained in MFGE8-overexpressed gastric cancer cells. Zinc finger and BTB domain containing 7 A (ZBTB7A) was a transcription factor of MFGE8. ZBTB7A overexpression eliminated the effect of MFGE8 on gastric cancer cells. MFGE8 activated the IL-6/JAK/STAT3 signaling. Inhibition of IL-6/JAK/STAT3 signaling by Stattic (pathway inhibitor) could eliminate the promoting effect of MFGE8 on IL-6/JAK/STAT3 signaling. In addition, MFGE8 shRNA inhibited tumor growth.</div></div><div><h3>Conclusion</h3><div>MFGE8 promoted cell proliferation, EMT progress, and tumor growth of gastric cancer by activating the IL-6/JAK/STAT3 signaling.</div></div>","PeriodicalId":9902,"journal":{"name":"Cellular signalling","volume":"125 ","pages":"Article 111486"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular signalling","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0898656824004613","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Gastric cancer is malignant cancer with high morbidity and mortality worldwide. Milk fat globule EGF and factor V/VIII domain containing (MFGE8) was involved in many cancers. Nevertheless, the role of MFGE8 in gastric cancer remained indistinct. To probe the role of MFGE8 in gastric cancer and further explore the regulating mechanism.

Methods

GEPIA was employed for analysis of MFGE8 expression and survival of gastric cancer patients. MFGE8 expression in gastric cancer was determined by immunohistochemistry, PCR, and western blot. The effect of MFGE8 on gastric cancer cells were evaluated by a series of cell function experiments. The mechanism of MFGE8 on gastric cancer was analyzed by GSEA and verified by in vitro and in vivo experiments.

Results

MFGE8 was over-expressed in gastric cancer. Silence of MFGE8 suppressed cell viability, proliferated ability, migrated and invasive ability, and EMT, but accelerated cell apoptosis. The opposite results were obtained in MFGE8-overexpressed gastric cancer cells. Zinc finger and BTB domain containing 7 A (ZBTB7A) was a transcription factor of MFGE8. ZBTB7A overexpression eliminated the effect of MFGE8 on gastric cancer cells. MFGE8 activated the IL-6/JAK/STAT3 signaling. Inhibition of IL-6/JAK/STAT3 signaling by Stattic (pathway inhibitor) could eliminate the promoting effect of MFGE8 on IL-6/JAK/STAT3 signaling. In addition, MFGE8 shRNA inhibited tumor growth.

Conclusion

MFGE8 promoted cell proliferation, EMT progress, and tumor growth of gastric cancer by activating the IL-6/JAK/STAT3 signaling.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
MFGE8通过激活IL-6/JAK/STAT3信号传导促进胃癌进展
目的胃癌是全世界发病率和死亡率都很高的恶性肿瘤。含有乳脂球 EGF 和因子 V/VIII 结构域(MFGE8)的蛋白与多种癌症有关。然而,MFGE8在胃癌中的作用仍不明确。方法采用GEPIA分析MFGE8的表达和胃癌患者的生存率。通过免疫组化、PCR和Western blot检测MFGE8在胃癌中的表达。通过一系列细胞功能实验评估了 MFGE8 对胃癌细胞的影响。结果MFGE8在胃癌中过度表达。沉默 MFGE8 可抑制细胞活力、增殖能力、迁移和侵袭能力以及 EMT,但可加速细胞凋亡。而 MFGE8 高表达的胃癌细胞则出现了相反的结果。锌指和含BTB结构域7 A(ZBTB7A)是MFGE8的转录因子。ZBTB7A 的过表达消除了 MFGE8 对胃癌细胞的影响。MFGE8激活了IL-6/JAK/STAT3信号传导。用Stattic(通路抑制剂)抑制IL-6/JAK/STAT3信号转导可以消除MFGE8对IL-6/JAK/STAT3信号转导的促进作用。结论MFGE8通过激活IL-6/JAK/STAT3信号促进胃癌细胞增殖、EMT进展和肿瘤生长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cellular signalling
Cellular signalling 生物-细胞生物学
CiteScore
8.40
自引率
0.00%
发文量
250
审稿时长
27 days
期刊介绍: Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo. Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.
期刊最新文献
Potential of quercitrin in psoriasis intervention: Dual regulation of the oxidative stress-NF-κB axis and gut microbiota homeostasis Peripheral regional anesthesia alleviates skeletal muscle injury and inflammation caused by acute compartment syndrome by inhibiting PI3K/AKT/NF-kB pathway and regulating macrophage polarization The role of the triggering receptor expressed on myeloid cells family in metabolic syndrome: A review Membrane receptor TGR5 upregulates IP3R-induced calcium overload: Key mechanism of bile acid-induced acute pancreatitis A novel diagnostic and prognostic biomarker FSD1L facilitates EMT and Lenvatinib resistance via the WNT/β-catenin pathway in hepatocellular carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1